Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 5901-5950 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05818709
A Study to Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult Participants
PHASE3Active, not recruiting
61 participants
Started: Jun 14, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor17 locations
NCT05811416
A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants
N/AActive, not recruiting
200 participants
Started: Jun 14, 2023 · Completed: Sep 26, 2025
1 condition1 sponsor1 location
NCT06175338
Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis
PHASE1Active, not recruiting
208 participants
Started: Jun 14, 2023 · Completed: Apr 30, 2025
1 condition1 sponsor12 locations
NCT05809115
Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story
N/AActive, not recruiting
2,000 participants
Started: Jun 14, 2023 · Completed: Mar 31, 2026
3 conditions2 sponsors1 location
NCT05785247
ENHANCE - Evaluating the Implementation of Head and Neck Cancer E-health
N/AActive, not recruiting
63 participants
Started: Jun 14, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05925920
Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes
PHASE1Active, not recruiting
49 participants
Started: Jun 13, 2023 · Completed: Dec 6, 2024
2 conditions1 sponsor1 location
NCT07140120
LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study
N/AActive, not recruiting
52 participants
Started: Jun 13, 2023 · Completed: Mar 31, 2026
2 conditions2 sponsors3 locations
NCT06212752
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension
PHASE3Active, not recruiting
39 participants
Started: Jun 13, 2023 · Completed: May 22, 2028
1 condition1 sponsor18 locations
NCT05926960
A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma
PHASE2Active, not recruiting
38 participants
Started: Jun 13, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors24 locations
NCT05745493
Study 1: Social Engage Coaching R61 Phase
NAActive, not recruiting
30 participants
Started: Jun 13, 2023 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT06449859
A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects
PHASE1Active, not recruiting
84 participants
Started: Jun 13, 2023 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05817942
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
N/AActive, not recruiting
520 participants
Started: Jun 12, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor81 locations
NCT05673187
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
PHASE2Active, not recruiting
68 participants
Started: Jun 12, 2023 · Completed: Mar 1, 2026
2 conditions2 sponsors22 locations
NCT05937308
NEUROMARK Registry Study
NAActive, not recruiting
150 participants
Started: Jun 12, 2023 · Completed: Sep 30, 2027
1 condition1 sponsor7 locations
NCT05835895
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
PHASE1Active, not recruiting
67 participants
Started: Jun 12, 2023 · Completed: May 31, 2029
3 conditions2 sponsors9 locations
NCT05764161
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
PHASE3Active, not recruiting
190 participants
Started: Jun 12, 2023 · Completed: Oct 25, 2025
1 condition1 sponsor76 locations
NCT05792566
ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Survivors of Childhood Cancer
NAActive, not recruiting
35 participants
Started: Jun 12, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06119724
Bipolar Enbloc Versus Thulium-Yag Enbloc Resection of Bladder Tumors
NAActive, not recruiting
50 participants
Started: Jun 11, 2023 · Completed: Dec 29, 2025
1 condition1 sponsor1 location
NCT05873673
Coenzyme Q10 and Dentoalveolar Cyst
PHASE2Active, not recruiting
20 participants
Started: Jun 11, 2023 · Completed: Apr 1, 2025
1 condition1 sponsor1 location
NCT05941481
Neoadjuvant Chemo-hypoRT Plus PD-1 Antibody (Tislelizumab) in Resectable LA-G/GEJ
PHASE2Active, not recruiting
21 participants
Started: Jun 10, 2023 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05760001
The IGNITE for Kids Study on Concentrated Investment in Black Neighborhoods and Child Health and Well-Being
NAActive, not recruiting
221 participants
Started: Jun 10, 2023 · Completed: Feb 17, 2026
6 conditions2 sponsors1 location
NCT05841537
An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
N/AActive, not recruiting
1,019 participants
Started: Jun 9, 2023 · Completed: Jul 31, 2028
1 condition1 sponsor154 locations
NCT06352996
Three-Dimensional Assessment of Maxillary Canine Retraction With and Without Power Arm
NAActive, not recruiting
20 participants
Started: Jun 9, 2023 · Completed: Jul 30, 2024
1 condition1 sponsor1 location
NCT05965973
Diet Impact on Hepatic Transcriptomics and Lipidomics in Pre-diabetes
NAActive, not recruiting
6 participants
Started: Jun 9, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05617014
Alzheimer's Disease Neuroimaging Initiative 4
N/AActive, not recruiting
1,500 participants
Started: Jun 9, 2023 · Completed: Jul 31, 2027
3 conditions4 sponsors57 locations
NCT06517303
Evaluation of the Implementation of Drug Prescription Recommendations Using Clinical Decision Support in Patients With Severe Obesity: Retrospective Study
N/AActive, not recruiting
1,050 participants
Started: Jun 9, 2023 · Completed: Jun 9, 2026
2 conditions2 sponsors2 locations
NCT04906824
Post-Market Registry in Europe and US for the Use of VascuCelTM
N/AActive, not recruiting
100 participants
Started: Jun 9, 2023 · Completed: Sep 30, 2026
3 conditions2 sponsors5 locations
NCT05934019
Efficacy of a Transdiagnostic Online Prevention Approach in Adolescents (EMPATIA)
NAActive, not recruiting
152 participants
Started: Jun 9, 2023 · Completed: Sep 30, 2025
7 conditions1 sponsor1 location
NCT05986695
Informational Nudge to Improve Heart Failure Prescribing
NAActive, not recruiting
89 participants
Started: Jun 9, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05303792
Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma
PHASE2Active, not recruiting
68 participants
Started: Jun 9, 2023 · Completed: May 31, 2028
2 conditions2 sponsors72 locations
NCT05590143
proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2
PHASE4Active, not recruiting
784 participants
Started: Jun 9, 2023 · Completed: Sep 30, 2025
3 conditions2 sponsors6 locations
NCT05855239
Quantification of Hepatic Steatosis With Different Ultrasound Frequency
N/AActive, not recruiting
120 participants
Started: Jun 8, 2023 · Completed: Dec 31, 2024
3 conditions2 sponsors1 location
NCT05597618
Empowerment Program for New Graduated Nurses
NAActive, not recruiting
68 participants
Started: Jun 8, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06624163
Evaluation of Patient Coach Support for Older Adults With Obesity
NAActive, not recruiting
19 participants
Started: Jun 8, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05938426
Digital Therapeutics Research on Efficiency About Mild Cognitive Impairment Study
NAActive, not recruiting
100 participants
Started: Jun 8, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05656560
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial
NAActive, not recruiting
786 participants
Started: Jun 8, 2023 · Completed: May 31, 2026
1 condition5 sponsors2 locations
NCT05890534
Pycnogenol® in Post-COVID-19 Condition
PHASE3Active, not recruiting
153 participants
Started: Jun 7, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT07084246
Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study
N/AActive, not recruiting
1,563 participants
Started: Jun 7, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05694871
Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
PHASE2Active, not recruiting
77 participants
Started: Jun 7, 2023 · Completed: May 31, 2027
6 conditions2 sponsors194 locations
NCT05646862
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
PHASE3Active, not recruiting
400 participants
Started: Jun 7, 2023 · Completed: Mar 30, 2029
1 condition1 sponsor152 locations
NCT05808010
Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis
NAActive, not recruiting
60 participants
Started: Jun 7, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05778071
Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism
PHASE3Active, not recruiting
165 participants
Started: Jun 7, 2023 · Completed: Jun 16, 2027
3 conditions2 sponsors54 locations
NCT05693649
Behavioral Economic Approaches for Population-Based Colorectal Cancer Screening
NAActive, not recruiting
20,000 participants
Started: Jun 7, 2023 · Completed: Dec 21, 2026
1 condition1 sponsor1 location
NCT05835778
Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
N/AActive, not recruiting
235 participants
Started: Jun 7, 2023 · Completed: Jul 17, 2026
1 condition1 sponsor32 locations
NCT05532176
Posture Standards of a New Dynamic Platform
NAActive, not recruiting
260 participants
Started: Jun 7, 2023 · Completed: Apr 4, 2026
1 condition1 sponsor1 location
NCT05888831
A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
100 participants
Started: Jun 6, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor20 locations
NCT05698823
Regular Home-use of Dual-light Photodynamic Therapy in the Management of Chronic Stage III-IV Periodontitis
NAActive, not recruiting
60 participants
Started: Jun 6, 2023 · Completed: Dec 31, 2027
2 conditions3 sponsors1 location
NCT05627323
CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
PHASE1Active, not recruiting
42 participants
Started: Jun 6, 2023 · Completed: Jan 31, 2041
1 condition1 sponsor2 locations
NCT05881135
Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET)
PHASE1/PHASE2Active, not recruiting
80 participants
Started: Jun 6, 2023 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT05912140
Assessment of Trunk Aesthetics: Development of a New Tool
N/AActive, not recruiting
600 participants
Started: Jun 6, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location